RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
RARX
Delisted
RARX was delisted on the 1st of April, 2020.
60 hedge funds and large institutions have $297M invested in Ra Pharmaceuticals, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 20 reducing their positions, and 4 closing their positions.
Holders
60
Holders Change
+1
Holders Change %
+1.69%
% of All Funds
1.5%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
12
Increased
15
Reduced
20
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
BlackRock
New York
|
$7.35M |
2 |
GTC
2
Ghost Tree Capital
New York
|
$6.39M |
3 |
VMI
3
VHCP Management II
New York
|
$15.4M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$5.75M |
5 |
EU
5
Emory University
Atlanta,
Georgia
|
$2.21M |